Tapan Bera
About Tapan Bera
Data last updated:
Tapan Bera has 7 years in corporate governance. Holds Director role. Currently with 2 companies, including Glynis Medicare Private Limited and Glynis Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Glynis Pharmaceutical Private Limited at ₹1.95 Cr (FY 2021).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Glynis Pharmaceutical Private Limited U24100WB2014PTC204567 | Director | 07 Jan 2019 | 2014 | ₹1.95 Cr (FY 2021) | Active |
 Glynis Medicare Private Limited U21001WB2023PTC260945 | Director | 09 Apr 2023 | 2023 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Tapan Bera
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tapan Bera
Tapan Bera has 7 years in corporate governance. Holds Director role. Currently with 2 companies, including Glynis Medicare Private Limited and Glynis Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Glynis Pharmaceutical Private Limited at ₹1.95 Cr (FY 2021).
Tapan Bera is associated with 2 companies as Director, including Glynis Pharmaceutical Private Limited (₹1.95 Cr), Glynis Medicare Private Limited.
Tapan Bera has expertise in General Business.
Tapan Bera has 7 years in corporate governance.
By reported revenue, the largest current company of Tapan Bera is Glynis Pharmaceutical Private Limited, with revenue of ₹1.95 Cr (FY 2021).
Tapan Bera currently holds positions at 2 companies: Glynis Pharmaceutical Private Limited (₹1.95 Cr), Glynis Medicare Private Limited.